SearchDictionaryMobileLogin

Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

AbstractOBJECTIVE: To characterize a new serum autoantibody in patients with systemic sclerosis (SSc) directed against U11/U12 RNP and to identify the clinical features associated with this autoantibody. METHODS: We identified autoantibodies directed against the U11/U12 RNP complex in sera of patients with SSc and confirmed antibody specificity by immunoprecipitation, reverse transcriptase-polymerase chain reaction, and Southern blotting. We determined the prevalence of these antibodies in SSc and their specificity for SSc. We compared anti-U11/U12 RNP autoantibody-positive and negative SSc patients on demographic, disease classification, clinical variables, and survival. RESULTS: We identified 33 patients with anti-U11/U12 RNP antibodies. In 2 consecutive series of SSc patients first seen at 10-year intervals (1994-1995 and 2004-2005), the prevalence of anti-U11/U12 RNP antibody-positive patients was 15 of 462 (3.2%). Seventeen (52%) of these 33 patients had limited cutaneous involvement. All patients had Raynaud's phenomenon and 82% had gastrointestinal (GI) involvement. None had "intrinsic" pulmonary arterial hypertension. The most significant clinical difference between anti-U11/U12 antibody-positive and negative cohorts was the prevalence of lung fibrosis, which occurred in 79% of the anti-U11/U12 RNP antibody-positive patients versus 37% of the anti-U11/U12 RNP antibody-negative patients (P < 0.0001). GI involvement was also significantly increased in the anti-U11/U12 RNP antibody-positive group. Patients with anti-U11/U12 RNP antibodies and pulmonary fibrosis had a 2.25-fold greater risk of death than anti-U11/U12 RNP negative patients with pulmonary fibrosis. CONCLUSION: Anti-U11/U12 RNP antibodies are present in the sera of approximately 3% of patients with SSc and are a marker for lung fibrosis, which is often severe.
AuthorsNoreen Fertig, Robyn T Domsic, Tatiana Rodriguez-Reyna, Masataka Kuwana, Mary Lucas, Thomas A Medsger Jr, Carol A Feghali-Bostwick (Affiliation: University of Pittsburgh, Pittsburgh, PA 15213, USA.)
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 61 Issue 7 Pg. 958-65 (Jul 15 2009) ISSN: 0004-3591 [Print] United States
PMID19565553 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Biological Markers
  • Ribonucleoproteins, Small Nuclear
  • U11/U12 small nuclear ribonucleoprotein
Topics
  • Adult
  • Antibody Specificity (immunology)
  • Autoantibodies (blood)
  • Biological Markers (blood)
  • Cohort Studies
  • Disease Progression
  • Female
  • Humans
  • Immunoprecipitation
  • Male
  • Middle Aged
  • Pulmonary Fibrosis (blood, diagnosis, mortality)
  • Ribonucleoproteins, Small Nuclear (immunology)
  • Scleroderma, Systemic (blood, complications, immunology)
  • Survival Rate